A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
University of Nebraska
Dana-Farber Cancer Institute
University of California, San Diego
Assistance Publique - Hôpitaux de Paris
Massachusetts General Hospital
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Instituto Nacional de Cancer, Brazil
St. Petersburg State Pavlov Medical University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Roswell Park Cancer Institute
Beijing 302 Hospital
University of Nebraska
University of Nebraska
Melbourne Health
First Affiliated Hospital of Zhejiang University
University of Liege
Kiadis Pharma
National Research Center for Hematology, Russia
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
Children's Oncology Group
Hospital Israelita Albert Einstein
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Dana-Farber Cancer Institute
Hospital Israelita Albert Einstein
Thomas Jefferson University
University of Rochester
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Mesoblast, Ltd.
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
OHSU Knight Cancer Institute